2022 Poster Presentations coming in July
2021 Presentations:
IP-01: Streamlining NGS-Based Workflows in Cell Line Development, Presented by Ivan S., Genedata AG
IP-02: LC-MS-Based Detection of Low-Abundance HCPs: Increased Sensitivity and Accuracy with Fewer False-Positive Identifications, Presented by David B., Genedata, Inc.
IP-03: Improving Targeting and Yield of AAV by Capsid and Producer Cell Line Engineering, Presented by Magdalena M., KTH - Royal Institute of Technology
IP-04: Smart Bioreactor with Integrated Flexible Sensors and Wireless Electronics, Presented by Yun-Soung K., Georgia Institute of Technology
IP-05: Formulation of a Novel Human Protein-Based MRI Contrast Agents, Presented by Florence R., Georgia State University
IP-06: Potency Assay Development for rAAV Vector Encoding Retinitis Pigmentosa GTPase Regulator (RPGRco), Presented by Geeta I., AGTC - Applied Genetic Technologies Corporation
IP-07: Accelerating Bioprocess Workflows with High-Throughput, Automated Platform for Impurities and Titer Analysis, Presented by Rob D., Gyros Protein Technologies
IP-08: The Role of the Stack Family Center for Biopharmaceutical Education and Training (CBET) at ACPHS in Responding to the Workforce Demands of the Biomanufacturing Industry, Presented by Ehsan M., Albany College of Pharmacy and Health Sciences
IP-09: Introducing the Aura CL for Cell Therapy Aggregation, Particle Analysis, and ID, Presented by Bernardo C., Halo Labs
IP-10: Introducing the Aura CL for Gene Therapy Physical Stability, Aggregation, and Particle Identification, Presented by Bernardo C., Halo Labs
IP-11: Protein or Not? Advanced Subvisible Particle Characterization with Fluorescent ID, Presented by Bernardo C., Halo Labs
IP-12: A Novel Tool to Enable Multivalent Vaccine Development for Influenza and Coronavirus, Presented by Damini P., InDevR, Inc.
IP-13: Effect of Storage Media and Shipping Temperature on Subvisible Particulate Matter and Viability in Cellular Therapeutics, Presented by Christine P., KBI Biopharma, Inc.
IP-14: Preliminary Evaluation of PendoTECH® Single Use Sensors Post X-Ray Irradiation, Presented by Nick T., PendoTECH
IP-15: How to Design Continuous Devices to Improve Tangential Flow Filtration and Product Quality in Protein Precipitation, Presented by Maria del Carme P., University of Natural Resources and Life Sciences (BOKU)
IP-16: On-Demand: Continuous Reconstitution of Cell Culture Media and Buffers Directly from Solids, Presented by Daniel K., University of Natural Resources and Life Sciences (BOKU)
IP-17: Residence Time Distribution of Continuous Capture Chromatography, Presented by Narges L., University of Natural Resources and Life Sciences (BOKU)
IP-18: Evaluation of an Online PAT Co-Laboratory for Rapid Process Development, Presented by Jens P., Lonza Walkersville, Inc.
IP-19: Stable Isotopic Labeling of 1,2 [13]C2-Glucose and 1,6 [13]C2-Glucose for Tracing CHO Cell and Mass Spectrometry-Based Metabolomics, Presented by Xin B., U.S. Food and Drug Administration
IP-20: Characterization of Recombinant Factor C Enzyme Critical Quality Attributes, Presented by Rachel C., U.S. Food and Drug Administration
IP-21: Next Generation Transfection Reagent for Large Scale AAV Manufacturing, Presented by Ashlee S., Polyplus-transfection
IP-22: Size, Shape, Count and Identification of Contaminants Using Total Holographic Characterization, Presented by Laura P., Spheryx, Inc.
IP-23: A Multiplex qPCR Based System to Quantitate Residual Plasmids with Kanamycin Resistance Genes for GMP Lot Release in Gene Therapy and Vaccine Manufacturing, Presented by Lisa Y., Thermo Fisher Scientific
IP-24: Imaging to Aid Cell-Based Assay Development for Gene Therapy Products, Presented by Elena B., Ultragenyx Gene Therapy
IP-25: Platform Development: Improving Harvest Clarification and Impurity Clearance for AAV Downstream Processes, Presented by Michael D., Ultragenyx Gene Therapy
IP-26: Proof of Concept for Automation to Miniaturize Ad Increase Throughput in qPCR Genome Titer Assay for AAV Vectors, Presented by Sara F., Ultragenyx Gene Therapy
IP-27: Development of Process Analytical Technology for AAV Transfection Methods, Presented by Kostantinos K., Ultragenyx Gene Therapy
IP-28: Intensification of Operations and Increased Run Rate in an rAAV Gene Therapy Pilot Plant, Presented by Amy M., Ultragenyx Gene Therapy
IP-29: Process Optimization for Expansion of Induced Pluripotent Stem Cells in a Stirred-Tank Bioreactor, Presented by Megan P., MilliporeSigma
IP-30: Methods to Monitor Aggregation in Human Cytomegalovirus Drug Substance, Presented by Ashley H., Merck & Co., Inc.
IP-31: ATF N-1/N Stage Perfusion Platform Process Development Using mAb Producing CHO Cell Culture, Presented by Xiaofeng H., JOINN Biologics US, Inc.
IP-32: Quantitation and Kinetics Using Gator® System, Presented by Chip S., Gator Bio, Inc.
IP-33: Analytical Methods to Support Formulation Development for Adeno-Associated Virus, Presented by Sabine H., Leukocare AG
IP-34: Estimated Viable Cell Concentration from Capacitance Measurements Using Multivariate Analysis in Fed-Batch Mammalian Cultures on Lonza Platform Processes, Presented by Marissa D., Lonza Biologics
V-01: Adventitious Virus Removal Capability of Adeno-Associated Virus Downstream Platform Manufacturing Process, Presented by Giuliana B., Ultragenyx Gene Therapy
V-02: Automated AAV Capsid Titer Assay on Gyros Immunoassay Platform, Presented by Matthew L., Ultragenyx Gene Therapy
V-03: Comparability Strategy for Pre-Clinical vs. Clinical Manufacturing Processes of Cell Therapy Products, Presented by Christopher V., Century Therapeutics, Inc.
V-04: Conversion of a Viral Glycoprotein Titer Method from ELISA to BLI, Presented by Aaron M., Cytovance Biologics
V-05: Focal Molography - Eliminating Guess Work in Biotech and Pharma Research, Presented by Volker G., lino Biotech AG
V-06: Bioreactor Digital Twins, Presented by Sarah F., Siemens Process Systems Engineering Ltd.
V-07: Integrated Mechanistic Modelling of a Full Monoclonal Antibody Production Process for Assuring Process Robustness in the Face of Upstream Variability, Presented by Edward C., Siemens Process Systems Engineering Ltd.
V-08: Platform Development and Scale-Up of the Spray Drying Process for cGMP Production of Protein Therapeutics, Presented by Noor B., Regeneron Pharmaceuticals, Inc.
V-09: Rapid mRNA Purification Using Novel Membrane Adsorbers, Presented by Graham T., Purilogics
V-10: Getting More with Less: Membrane-Based Antibody Chromatography and You, Presented by Jinxiang Z., Purilogics